A case study of personalized therapy for osteosarcoma-Reference-Cited by-同舟云学术

A case study of personalized therapy for osteosarcoma

Published:2013-03-22 Issue:8 Volume:60 Page:1313-1319
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Davis Lara E.¹²³⁴,Hofmann Nicolle E.¹,Li Guangheng¹,Huang Elaine T.¹,Loriaux Marc M.⁴⁵,Bracha Shay⁶,Helfand Stuart C.⁶,Mata John E.⁶,Marley Kevin⁶,Mansoor Atiya⁵,Tyner Jeffrey W.³⁴,Abraham Jinu¹,Séguin Bernard⁶,Keller Charles¹⁴

Affiliation:

1. Pediatric Cancer Biology Program, Papé Family Pediatric Research Institute; Oregon Health & Sciences University; Portland, Oregon

2. Division of Pediatric Hematology and Oncology, Department of Pediatrics; Oregon Health & Sciences University; Portland, Oregon

3. Division of Hematology and Medical Oncology, Department of Medicine; Oregon Health & Sciences University; Portland, Oregon

4. Knight Cancer Institute; Oregon Health & Sciences University; Portland, Oregon

5. Department of Pathology; Oregon Health & Sciences University; Portland, Oregon

6. College of Veterinary Medicine; Oregon State University; Corvallis, Oregon

Funder

Thrasher Research Fund Early Career Award

Scott Carter Foundation

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24512/fullpdf

Reference13 articles.

1. Altekruse SF Kosary CL Krapcho M SEER Cancer Statistics Review, 1975-2007 National Cancer Institute

2. A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-Vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors;Fox;J Clin Oncol,2010

3. Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer;Herbst;J Clin Oncol,2010

4. A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors;Kurzrock;Clin Cancer Res,2010

5. Cross talk from pets to people: Translational osteosarcoma treatments;Withrow;ILAR J,2010

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Medicine in Veterinary Science;Veterinary Clinics of North America: Small Animal Practice;2024-05

2. Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines;International Journal of Molecular Sciences;2022-08-19

3. Canine models of human cancer: Bridging the gap to improve precision medicine;Progress in Molecular Biology and Translational Science;2022

4. Molecular targets for anticancer therapies in companion animals and humans: what can we learn from each other?;Theranostics;2021

5. Targeting Mechanotransduction in Osteosarcoma: A Comparative Oncology Perspective;International Journal of Molecular Sciences;2020-10-14